
Partner
King & Spalding LLP
Columns
Title | Category | Published |
---|---|---|
Mifepristone debate could jeopardize access to many other FDA-approved drugs | Health Care & Hospital Law, Government | May 12, 2023 |
Title | Category | Published |
---|---|---|
Mifepristone debate could jeopardize access to many other FDA-approved drugs | Health Care & Hospital Law, Government | May 12, 2023 |